Ticker Symbol: GHRS
GH Research PLC
$23.02 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Ireland
Currency:
USD
Asset
Type: Common Stock
CIK:0001855129
Company Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 28 Baggot Street
Website: www.ghres.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $8.08
Change:
$0.02
(
0.25%)
Days Range: $7.70 - $8.28
Beta: 0.73
52wk. High: $14.64
52wk. Low: $5.70
Ytd. Change -16.62%
50 Day Moving Average: $9.49
200 Day Moving Average: $10.70
Shares Outstanding: 52020849
Valuation
Market Cap: 42.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A